ENZN
Price
$0.08
Change
-$0.00 (-0.00%)
Updated
Jul 28 closing price
Capitalization
5.62M
INCY
Price
$77.17
Change
+$7.01 (+9.99%)
Updated
Jul 29, 02:57 PM (EDT)
Capitalization
13.58B
Earnings call today
Interact to see
Advertisement

ENZN vs INCY

Header iconENZN vs INCY Comparison
Open Charts ENZN vs INCYBanner chart's image
Enzon Pharmaceuticals
Price$0.08
Change-$0.00 (-0.00%)
Volume$29.63K
Capitalization5.62M
Incyte
Price$77.17
Change+$7.01 (+9.99%)
Volume$500
Capitalization13.58B
ENZN vs INCY Comparison Chart in %
Loading...
ENZN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INCY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ENZN vs. INCY commentary
Jul 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ENZN is a Hold and INCY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 29, 2025
Stock price -- (ENZN: $0.08 vs. INCY: $70.16)
Brand notoriety: ENZN: Not notable vs. INCY: Notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ENZN: 38% vs. INCY: 105%
Market capitalization -- ENZN: $5.62M vs. INCY: $13.58B
ENZN [@Biotechnology] is valued at $5.62M. INCY’s [@Biotechnology] market capitalization is $13.58B. The market cap for tickers in the [@Biotechnology] industry ranges from $316.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ENZN’s FA Score shows that 1 FA rating(s) are green whileINCY’s FA Score has 1 green FA rating(s).

  • ENZN’s FA Score: 1 green, 4 red.
  • INCY’s FA Score: 1 green, 4 red.
According to our system of comparison, INCY is a better buy in the long-term than ENZN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ENZN’s TA Score shows that 2 TA indicator(s) are bullish while INCY’s TA Score has 4 bullish TA indicator(s).

  • ENZN’s TA Score: 2 bullish, 7 bearish.
  • INCY’s TA Score: 4 bullish, 2 bearish.
According to our system of comparison, INCY is a better buy in the short-term than ENZN.

Price Growth

ENZN (@Biotechnology) experienced а -9.17% price change this week, while INCY (@Biotechnology) price change was +4.13% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.43%. For the same industry, the average monthly price growth was +17.03%, and the average quarterly price growth was +42.26%.

Reported Earning Dates

INCY is expected to report earnings on Jul 29, 2025.

Industries' Descriptions

@Biotechnology (+4.43% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
INCY($13.6B) has a higher market cap than ENZN($5.62M). INCY has higher P/E ratio than ENZN: INCY (350.80) vs ENZN (96.10). INCY YTD gains are higher at: 1.578 vs. ENZN (-51.473). INCY has higher annual earnings (EBITDA): 407M vs. ENZN (-2M). INCY has more cash in the bank: 2.41B vs. ENZN (45M). INCY has less debt than ENZN: INCY (43.1M) vs ENZN (116M). INCY has higher revenues than ENZN: INCY (4.41B) vs ENZN (26K).
ENZNINCYENZN / INCY
Capitalization5.62M13.6B0%
EBITDA-2M407M-0%
Gain YTD-51.4731.578-3,262%
P/E Ratio96.10350.8027%
Revenue26K4.41B0%
Total Cash45M2.41B2%
Total Debt116M43.1M269%
FUNDAMENTALS RATINGS
ENZN vs INCY: Fundamental Ratings
ENZN
INCY
OUTLOOK RATING
1..100
7158
VALUATION
overvalued / fair valued / undervalued
1..100
83
Overvalued
92
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9789
PRICE GROWTH RATING
1..100
9051
P/E GROWTH RATING
1..100
108
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ENZN's Valuation (83) in the Biotechnology industry is in the same range as INCY (92). This means that ENZN’s stock grew similarly to INCY’s over the last 12 months.

ENZN's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as INCY (100). This means that ENZN’s stock grew similarly to INCY’s over the last 12 months.

INCY's SMR Rating (89) in the Biotechnology industry is in the same range as ENZN (97). This means that INCY’s stock grew similarly to ENZN’s over the last 12 months.

INCY's Price Growth Rating (51) in the Biotechnology industry is somewhat better than the same rating for ENZN (90). This means that INCY’s stock grew somewhat faster than ENZN’s over the last 12 months.

INCY's P/E Growth Rating (8) in the Biotechnology industry is in the same range as ENZN (10). This means that INCY’s stock grew similarly to ENZN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ENZNINCY
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
58%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
63%
MACD
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
63%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
63%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
59%
Advances
ODDS (%)
Bullish Trend 15 days ago
75%
Bullish Trend 7 days ago
60%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
61%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
50%
View a ticker or compare two or three
Interact to see
Advertisement
ENZN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INCY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IBM263.213.49
+1.34%
International Business Machines Corp
LILAK6.80N/A
N/A
Liberty Latin America Ltd
BC60.31-0.48
-0.79%
Brunswick Corp
CDRO8.35-0.10
-1.18%
Codere Online Luxembourg SA
PODC1.87-0.02
-1.26%
PodcastOne

ENZN and

Correlation & Price change

A.I.dvisor tells us that ENZN and CLDX have been poorly correlated (+8% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ENZN and CLDX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ENZN
1D Price
Change %
ENZN100%
-5.61%
CLDX - ENZN
8%
Poorly correlated
-5.74%
HALO - ENZN
2%
Poorly correlated
-1.77%
INCY - ENZN
2%
Poorly correlated
-0.06%
EXEL - ENZN
2%
Poorly correlated
-2.65%
ERNA - ENZN
-4%
Poorly correlated
-2.05%
More

INCY and

Correlation & Price change

A.I.dvisor indicates that over the last year, INCY has been loosely correlated with TECH. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if INCY jumps, then TECH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INCY
1D Price
Change %
INCY100%
-0.06%
TECH - INCY
42%
Loosely correlated
-0.39%
REGN - INCY
39%
Loosely correlated
-0.79%
SYRE - INCY
38%
Loosely correlated
-4.55%
AGIO - INCY
38%
Loosely correlated
-7.00%
RNAC - INCY
37%
Loosely correlated
+2.78%
More